☰

Sara K. Holt, Ph.D. - Publications

Affiliations: 
2006 University of Washington, Seattle, Seattle, WA 
Area:
Epidemiology, Oncology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Winters BR, Wright JL, Holt SK, Lin DW, Ellis WJ, Dalkin BL, Schade G. Extreme Gleason Upgrading From Biopsy to Radical Prostatectomy: A Population-Based Analysis. Urology. PMID 27313123 DOI: 10.1016/j.urology.2016.04.058  0.325
2013 Holt SK, Kwon EM, Fu R, Kolb S, Feng Z, Ostrander EA, Stanford JL. Association of variants in estrogen-related pathway genes with prostate cancer risk Prostate. 73: 1-10. PMID 22549291 DOI: 10.1002/Pros.22534  0.364
2012 Kwon EM, Holt SK, Fu R, Kolb S, Williams G, Stanford JL, Ostrander EA. Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. Cancer Epidemiology. 36: 347-53. PMID 22542949 DOI: 10.1016/J.Canep.2012.04.002  0.385
2011 FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1196-203. PMID 21467234 DOI: 10.1158/1055-9965.Epi-10-1299  0.344
2010 Holt SK, Kwon EM, Lin DW, Ostrander EA, Stanford JL. Association of hepsin gene variants with prostate cancer risk and prognosis. The Prostate. 70: 1012-9. PMID 20166135 DOI: 10.1002/Pros.21135  0.429
2009 Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL. Vitamin D pathway gene variants and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1929-33. PMID 19454612 DOI: 10.1158/1055-9965.Epi-09-0113  0.335
2009 Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer. 100: 412-20. PMID 19127255 DOI: 10.1038/Sj.Bjc.6604820  0.426
2008 Holt SK, Salinas CA, Stanford JL. Vasectomy and the risk of prostate cancer. The Journal of Urology. 180: 2565-7; discussion 2. PMID 18930503 DOI: 10.1016/J.Juro.2008.08.042  0.309
2008 Holt SK, Karyadi DM, Kwon EM, Stanford JL, Nelson PS, Ostrander EA. Association of megalin genetic polymorphisms with prostate cancer risk and prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3823-31. PMID 18559602 DOI: 10.1158/1078-0432.Ccr-07-4566  0.307
2007 Holt SK, Rossing MA, Malone KE, Schwartz SM, Weiss NS, Chen C. Ovarian cancer risk and polymorphisms involved in estrogen catabolism. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 481-9. PMID 17372243 DOI: 10.1093/Aje/163.Suppl_11.S253-C  0.428
Show low-probability matches.